Welcome to our dedicated page for McKesson news (Ticker: MCK), a resource for investors and traders seeking the latest updates and insights on McKesson stock.
McKesson Corporation (symbol: MCK) is a leading healthcare services and information technology company, dedicated to improving the business of healthcare globally. Ranked 11th on the Fortune 500 list, McKesson collaborates with a diverse range of stakeholders including payers, hospitals, physician offices, pharmacies, pharmaceutical companies, and other entities across the healthcare spectrum. The company's mission is to foster healthier organizations that deliver superior care to patients in every setting.
McKesson is one of the top three pharmaceutical wholesalers in the United States, engaging in the sourcing and distribution of branded, generic, and specialty pharmaceutical products. Their extensive client base includes retail chains, independent pharmacies, mail-order pharmacies, hospital networks, and healthcare providers. Alongside Cencora and Cardinal Health, McKesson commands over 90% of the US pharmaceutical wholesale industry.
Beyond the US, McKesson's reach extends to Canada, where they are involved in pharmaceutical wholesale and distribution. Additionally, McKesson supplies medical-surgical products and equipment to healthcare facilities and offers a range of technology solutions tailored for pharmacies.
McKesson's comprehensive service offerings include pharmaceutical and medical-surgical supply management, healthcare information technology solutions, and business and clinical services. The company is committed to helping its customers enhance their financial, operational, and clinical performance, ultimately aiming to deliver better patient care.
Recent achievements include strategic partnerships and innovative projects that continue to position McKesson as a key player in the healthcare industry. Their ongoing projects are designed to streamline operations and improve efficiency across the board, ensuring that healthcare providers can focus on patient care.
For more details on McKesson Corporation, visit www.mckesson.com.
McKesson Corporation (NYSE: MCK) has agreed to sell its Austrian operations to Quadrifolia Management GmbH. This deal includes McKesson Austria’s Herba Chemosan Apotheker-AG and Sanova Pharma GesmbH, expected to close in fiscal 2022 following regulatory approvals. CEO Brian Tyler stated this aligns with McKesson's strategy to streamline its portfolio and exit the European market, following previous agreements in the UK, France, Italy, Ireland, Portugal, Belgium, and Slovenia.
McKesson Corporation (NYSE: MCK) is hosting an Investor Day at 1:00 p.m. ET today to outline its strategy for sustainable growth. The event will cover progress in healthcare services and reaffirm commitments to expanding oncology and biopharma services. McKesson increased its fiscal 2022 Adjusted Earnings per Diluted Share guidance to $22.35-$22.95, boosted by the U.S. government's COVID-19 vaccine program. Additionally, a $4.0 billion share repurchase program was announced, highlighting a focus on shareholder value.
McKesson Corporation (NYSE: MCK) is set to host an Investor Day on December 8, 2021, from 1:00 PM to 4:00 PM ET in New York City. The event will include presentations by the leadership team, a live Q&A with CEO Brian Tyler and CFO Britt Vitalone, and discussions on the company’s progress towards sustainable growth and long-term financial outlook.
A video webcast will be available live and archived on McKesson's Investor Relations website.
Walgreens Boots Alliance (WBA) has announced its agreement to acquire the remaining 30% share of its joint venture with McKesson Corporation (MCK) in Germany, making WBA the sole owner of GEHE Pharma Handel and Alliance Healthcare Deutschland. This acquisition is part of McKesson's strategy to fully exit the European market. The transaction's financial terms were not disclosed and are subject to regulatory approval. This move aims to strengthen WBA's presence in the German pharmaceutical distribution market.
McKesson Corporation (NYSE: MCK) has released its fiscal 2022 second-quarter financial results. The earnings call is scheduled for November 1 at 4:30 PM ET, and results can be accessed on McKesson’s Investor Relations website. The company is recognized as a leader in healthcare supply chain management and has received accolades such as being named the "Most Admired Company" in its sector by FORTUNE. For further details, visit investor.mckesson.com/financials/quarterly-results.
McKesson Corporation (NYSE: MCK) has announced plans to sell its UK businesses to AURELIUS as part of its strategy to fully exit the European market. This includes the sale of entities like LloydsPharmacy and AAH Pharmaceuticals. The transaction is set to close in fiscal 2022, pending regulatory approvals. CEO Brian Tyler emphasized that this move allows for better long-term growth opportunities for the UK operations while enabling McKesson to focus on strategic investments outside Europe. This sale follows a previous agreement to divest businesses in several European countries.
The Board of Directors of McKesson Corporation (NYSE:MCK) has declared a regular dividend of 47 cents per share of common stock. This dividend will be payable on January 3, 2022, to stockholders of record as of December 1, 2021. This announcement highlights McKesson's commitment to returning value to its shareholders while maintaining its position as a leader in healthcare supply chain management and services.
Hercules Capital has appointed Pam Randhawa to its Board of Directors, effective November 1, 2021. With over 20 years in the healthcare and life sciences sectors, her background includes leadership positions at McKesson and her own firm, Empiriko Corporation. Randhawa's expertise is expected to enhance the board's capabilities as Hercules focuses on long-term growth and shareholder returns. CEO Scott Bluestein praised her contributions within the life sciences community, indicating her appointment is part of a strategy to bolster the company's leadership team.
AmerisourceBergen (ABC), Cardinal Health (CAH), and McKesson (MCK) have settled opioid-related claims with the Cherokee Nation for approximately $75 million over 6.5 years. This agreement resolves ongoing litigation and allows the companies to focus on safe medication delivery. The settlement is part of broader negotiations with federally recognized Native American tribes, despite the companies disputing the allegations against them. The firms emphasize their commitment to addressing the opioid epidemic's impact on communities.
McKesson Corporation (NYSE: MCK) is set to release its second quarter fiscal 2022 financial results on November 1, 2021, after market close. The earnings conference call will take place at 4:30 PM Eastern Time, which will be available via a live webcast on McKesson's Investor Relations website. Investors can access the earnings press release, financial tables, and slide presentation online following the conference.
FAQ
What is the current stock price of McKesson (MCK)?
What is the market cap of McKesson (MCK)?
What services does McKesson Corporation provide?
Where does McKesson Corporation operate?
Who are McKesson's primary clients?
What makes McKesson a leading pharmaceutical wholesaler?
How does McKesson help improve healthcare delivery?
What are some recent achievements of McKesson Corporation?
Can individuals buy products directly from McKesson?
How does McKesson contribute to the healthcare industry?
What is the significance of McKesson's partnerships?
Where can I find more information about McKesson Corporation?
